At the beginning of his first term in office U.S. President Barack Obama overturned President George W. Bush's existing executive order that banned federal funding of human embryonic stem cells (hESC) research with the exception of a small number of existing stem cell lines. Read More
A little over a year after Alkermes plc completed its acquisition of Elan Drug Technologies (EDT), the drug delivery organization of Elan Corp., the now Irish-based company is clearly reaping the rewards from the acquisition. (See BioWorld International, May 11, 2011, and Sept. 21, 2011.) Read More
Gene therapy has certainly had its share of drama even by the standards of the biotech world, where life-and-death situations are, in many indications, par for the course. But with improved safety, it is now being tested even in indications that are more about quality of life, not life or death. Read More
